Award

Delivery Order #SPE2DR26FN4H4

AmerisourceBergen Drug Corp Delivery Order for Novolog Insulin Vials

Buyer

Defense Logistics Agency

Award Amount

$3,252.68

Ceiling

$3,252.68

Awarded

February 24, 2026

Period of Performance

Feb 24, 2026 – Feb 25, 2026

Identifier

SPE2DR26FN4H4

NAICS

424210

This award represents a delivery order contract issued under an existing Indefinite Delivery Vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The order procures Novolog insulin in 100 unit/ml 10 ml vials, critical for managing diabetes and supporting public health initiatives. The delivery order is a short-term, specific procurement facilitating timely supply to meet immediate healthcare needs at the Conshohocken, PA location. Given it is issued under a long-term multi-year IDV contract focused on pharmaceutical distribution, this delivery order ensures the continuation of essential medication availability within federal healthcare systems. The order was not competitively bid, consistent with the IDV’s structure, allowing streamlined procurement. The contract period covers one day, reflecting prompt fulfillment requirements. This transaction complements AmerisourceBergen’s ongoing role in delivering pharmaceutical products under the broader 2025-2036 IDV contract, maintaining critical medicine supply chains for government health programs.

Description

4570940980!NOVOLOG 100 UNIT/ML VIAL 10ML

View original record